Laxygal

Sodium picosulfate, the active ingredient in Laxygal, is a stimulant laxative presented as an oral formulation for oral use. It is employed to relieve constipation and to prepare the bowel for diagnostic examinations such as colonoscopy in adult patients. The drug is marketed in the European Union and complies with relevant regulatory standards for quality and safety.

GNH USA supplies Laxygal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and the Americas.

Sodium picosulfate is used as a stimulant laxative to promote bowel evacuation in several clinical situations. - Constipation: facilitates regular bowel movements by increasing intestinal peristalsis and water content. - Colonoscopy preparation: clears the colon to improve visualization during the procedure. - Other diagnostic bowel preparation: used before radiologic examinations such as sigmoidoscopy or barium enema to achieve adequate cleansing.

Sodium picosulfate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Abdominal cramps: mild to moderate discomfort in the lower abdomen. - Diarrhea: loose, watery stools occurring after dosing. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Severe dehydration: marked loss of fluids leading to dizziness or low blood pressure. - Electrolyte imbalance: abnormal levels of sodium, potassium or chloride. - Allergic reaction: rash, itching, swelling or difficulty breathing.

When prescribing sodium picosulfate, clinicians should consider several safety measures to minimise risks. - Assess renal function: impaired kidneys may affect fluid balance. - Review electrolyte status: pre‑existing abnormalities increase risk of imbalance. - Avoid concurrent use with other laxatives: may cause excessive bowel stimulation. - Caution in patients with inflammatory bowel disease: may exacerbate symptoms. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium picosulfate can interact with certain medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticholinergic agents: may reduce laxative effect. - Opioid analgesics: can counteract stimulant action and cause constipation. - Diuretics: increase risk of dehydration and electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Mineral supplements (e.g., calcium, iron): may decrease absorption of the drug. - Antihypertensive drugs: enhanced hypotensive effect due to fluid loss. - NSAIDs: potential for renal impairment when combined with dehydration.